Literature DB >> 21776416

RASSF1A: Not a prototypical Ras effector.

Marilyn Gordon1, Shairaz Baksh.   

Abstract

The Ras association domain family (RASSF) of genes are commonly silenced by promoter specific methylation in human cancers. After the cloning of the first two family members in early 2000 (RASSF1 and RASSF5), eight other related genes have been identified (RASSF2, 3, 4 and 6-10). The unifying motif amongst all RASSF family members is the presence of the Ras association (RA) domain that could potentially associate with the Ras family of GTPases. Detailed analyses have determined that RASSF family members are tumor suppressor proteins, activators of cell death, cell cycle modulators, microtubule stabilizers and possibly inflammatory mediators linked to NFκB. As such, exploring the biological function of this gene family is needed and if indeed RASSF proteins could be the missing link between Ras signaling and apoptosis. Several RASSF family members have been demonstrated to associate with Ras. However, there is still controversy regarding the ability of RASSF1A to utilize Ras to promote cell death and of the importance of the RASSF1A RA domain. The focus of this review is to highlight the importance of Ras binding to the RASSF family of proteins and discuss what we currently know about the biology of RASSF1A.

Entities:  

Year:  2011        PMID: 21776416      PMCID: PMC3136945          DOI: 10.4161/sgtp.2.3.16286

Source DB:  PubMed          Journal:  Small GTPases        ISSN: 2154-1248


  59 in total

1.  Local activation of Rap1 contributes to directional vascular endothelial cell migration accompanied by extension of microtubules on which RAPL, a Rap1-associating molecule, localizes.

Authors:  Hisakazu Fujita; Shigetomo Fukuhara; Atsuko Sakurai; Akiko Yamagishi; Yuji Kamioka; Yoshikazu Nakaoka; Michitaka Masuda; Naoki Mochizuki
Journal:  J Biol Chem       Date:  2004-11-29       Impact factor: 5.157

2.  Ras/MEK signaling suppresses Myc-dependent apoptosis in cells transformed by c-myc and activated ras.

Authors:  M Tsuneoka; E Mekada
Journal:  Oncogene       Date:  2000-01-06       Impact factor: 9.867

Review 3.  The tumor suppressor RASSF1A in human carcinogenesis: an update.

Authors:  R Dammann; U Schagdarsurengin; C Seidel; M Strunnikova; M Rastetter; K Baier; G P Pfeifer
Journal:  Histol Histopathol       Date:  2005-04       Impact factor: 2.303

4.  RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family.

Authors:  Kristin Eckfeld; Luke Hesson; Michele D Vos; Ivan Bieche; Farida Latif; Geoffrey J Clark
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

Review 5.  The RASSF1A tumor suppressor.

Authors:  Howard Donninger; Michele D Vos; Geoffrey J Clark
Journal:  J Cell Sci       Date:  2007-09-15       Impact factor: 5.285

6.  Regulation of proapoptotic mammalian ste20-like kinase MST2 by the IGF1-Akt pathway.

Authors:  Donghwa Kim; Shaokun Shu; Marc D Coppola; Satoshi Kaneko; Zeng-Qiang Yuan; Jin Q Cheng
Journal:  PLoS One       Date:  2010-03-09       Impact factor: 3.240

7.  Mitotic kinase Aurora-A phosphorylates RASSF1A and modulates RASSF1A-mediated microtubule interaction and M-phase cell cycle regulation.

Authors:  R Rong; L Y Jiang; M S Sheikh; Y Huang
Journal:  Oncogene       Date:  2007-06-11       Impact factor: 9.867

8.  MST kinases monitor actin cytoskeletal integrity and signal via c-Jun N-terminal kinase stress-activated kinase to regulate p21Waf1/Cip1 stability.

Authors:  Ruth M Densham; Eric O'Neill; June Munro; Ireen König; Kurt Anderson; Walter Kolch; Michael F Olson
Journal:  Mol Cell Biol       Date:  2009-10-12       Impact factor: 4.272

9.  Activation of the c-Jun N-terminal kinase pathway by MST1 is essential and sufficient for the induction of chromatin condensation during apoptosis.

Authors:  Seiji Ura; Hiroshi Nishina; Yukiko Gotoh; Toshiaki Katada
Journal:  Mol Cell Biol       Date:  2007-06-04       Impact factor: 4.272

10.  Depletion of the Ras association domain family 1, isoform A-associated novel microtubule-associated protein, C19ORF5/MAP1S, causes mitotic abnormalities.

Authors:  Ashraf Dallol; Wendy N Cooper; Fahd Al-Mulla; Angelo Agathanggelou; Eamonn R Maher; Farida Latif
Journal:  Cancer Res       Date:  2007-01-15       Impact factor: 12.701

View more
  16 in total

1.  Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study.

Authors:  Kala Visvanathan; MaryJo S Fackler; Zhe Zhang; Zoila A Lopez-Bujanda; Stacie C Jeter; Lori J Sokoll; Elizabeth Garrett-Mayer; Leslie M Cope; Christopher B Umbricht; David M Euhus; Andres Forero; Anna M Storniolo; Rita Nanda; Nancy U Lin; Lisa A Carey; James N Ingle; Saraswati Sukumar; Antonio C Wolff
Journal:  J Clin Oncol       Date:  2016-11-21       Impact factor: 44.544

2.  Methylation pattern of oncogene HRAS gene promoter region and its clinical relevance to urocystic tumorigenesis.

Authors:  Xiao-Feng Sun; Lan Li; Xiu-Juan Li; Wei Shen
Journal:  Mol Biol Rep       Date:  2012-06-19       Impact factor: 2.316

3.  Differential methylation of the promoter and first exon of the RASSF1A gene in hepatocarcinogenesis.

Authors:  Surbhi Jain; Lijia Xie; Batbold Boldbaatar; Selena Y Lin; James P Hamilton; Stephen J Meltzer; Shun-Hua Chen; Chi-Tan Hu; Timothy M Block; Wei Song; Ying-Hsiu Su
Journal:  Hepatol Res       Date:  2014-12-09       Impact factor: 4.288

Review 4.  Protein kinases of the Hippo pathway: regulation and substrates.

Authors:  Joseph Avruch; Dawang Zhou; Julien Fitamant; Nabeel Bardeesy; Fan Mou; Laura Regué Barrufet
Journal:  Semin Cell Dev Biol       Date:  2012-08-09       Impact factor: 7.727

Review 5.  DNA markers in molecular diagnostics for hepatocellular carcinoma.

Authors:  Ying-Hsiu Su; Selena Y Lin; Wei Song; Surbhi Jain
Journal:  Expert Rev Mol Diagn       Date:  2014-08-07       Impact factor: 5.225

6.  A comprehensive analysis of RAS-effector interactions reveals interaction hotspots and new binding partners.

Authors:  Soheila Rezaei Adariani; Neda S Kazemein Jasemi; Farhad Bazgir; Christoph Wittich; Ehsan Amin; Claus A M Seidel; Radovan Dvorsky; Mohammad R Ahmadian
Journal:  J Biol Chem       Date:  2021-04-27       Impact factor: 5.157

7.  Pathogenetic and Prognostic Significance of Inactivation of RASSF Proteins in Human Hepatocellular Carcinoma.

Authors:  Diego F Calvisi; Matthias Evert; Frank Dombrowski
Journal:  Mol Biol Int       Date:  2012-04-02

8.  RASSF1 Polymorphisms in Cancer.

Authors:  Marilyn Gordon; Mohamed El-Kalla; Shairaz Baksh
Journal:  Mol Biol Int       Date:  2012-05-31

9.  Hippo and rassf1a Pathways: A Growing Affair.

Authors:  Francesca Fausti; Silvia Di Agostino; Andrea Sacconi; Sabrina Strano; Giovanni Blandino
Journal:  Mol Biol Int       Date:  2012-07-05

10.  RASSF1A Signaling in the Heart: Novel Functions beyond Tumor Suppression.

Authors:  Dominic P Del Re; Junichi Sadoshima
Journal:  Mol Biol Int       Date:  2012-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.